Original language | English |
---|---|
Pages (from-to) | 592-593 |
Number of pages | 2 |
Journal | Transplantation and Cellular Therapy |
Volume | 29 |
Issue number | 10 |
DOIs |
|
State | Published - Oct 2023 |
Externally published | Yes |
Keywords
- Acute lymphoblastic leukemia
- Children and young adults
- Chimeric antigen receptor T-cells
- Immunotherapy
- Relapse
- Salvage therapy
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Transplantation and Cellular Therapy, Vol. 29, No. 10, 10.2023, p. 592-593.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - Introduction to the Reports from the Insights in Pediatric CAR T-cell Immunotherapy
T2 - Recent Advances and Future Directions (INSPIRED) Symposium
AU - Schultz, Liora
AU - Jacoby, Elad
AU - Lamble, Adam J.
AU - Maude, Shannon L.
AU - McNerney, Kevin O.
AU - Moskop, Amy
AU - Myers, Regina M.
AU - Pulsipher, Michael A.
AU - Shah, Nirali N.
N1 - Funding Information: Financial disclosure: Support by National Institutes of Health Grant UG1HL069254 and a grant from the St. Baldrick's Foundation Johnny Christopher Fund. Funding Information: The authors acknowledge the speakers and chairs of the INSPIRED Symposium ( https://ncifrederick.cancer.gov/events/conferences/INSPIRED2023 ) for their contributions, and also thank the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) and the National Cancer Institute Intramural Research Program for their support of this meeting. Funding Information: The authors acknowledge the speakers and chairs of the INSPIRED Symposium (https://ncifrederick.cancer.gov/events/conferences/INSPIRED2023) for their contributions, and also thank the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) and the National Cancer Institute Intramural Research Program for their support of this meeting. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. N.N.S is supported by the Intramural Program of the NCI (ZIA BC 011823). Financial disclosure: Support by National Institutes of Health Grant UG1HL069254 and a grant from the St. Baldrick's Foundation Johnny Christopher Fund. Conflict of interest statement: L.M.S. reports serving on advisory boards for Novartis and Cargo Therapeutics. E.J. reports receiving honoraria from Novartis. S.L.M reports clinical trial support: Novartis, Wugen; consulting, advisory boards, or study steering committee: Novartis, and patent pending and licensed to Novartis Pharmaceuticals for PCT/US2017/044425: Combination Therapies for Car and PD-1 Inhibitors. M.A.P. reports serving on advisory boards for Cargo Therapeutics, Novartis, Gentibio, Bluebird, Vertex, Medexus, and Equillium; receiving study support from Adaptive and Miltenyi. N.N.S. reports attending advisory board meetings for Sobi and VOR. Authorship statement: N.N.S drafted the first version of this manuscript, however all authors provided substantial edits and input into the concept and manuscript writing. All authors provided final approval of manuscript and all authors are accountable for all aspects of work. Financial disclosure: See Acknowledgments on page XXXX. Funding Information: The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. N.N.S is supported by the Intramural Program of the NCI (ZIA BC 011823).
PY - 2023/10
Y1 - 2023/10
KW - Acute lymphoblastic leukemia
KW - Children and young adults
KW - Chimeric antigen receptor T-cells
KW - Immunotherapy
KW - Relapse
KW - Salvage therapy
UR - http://www.scopus.com/inward/record.url?scp=85167985127&partnerID=8YFLogxK
U2 - 10.1016/j.jtct.2023.07.009
DO - 10.1016/j.jtct.2023.07.009
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
C2 - 37442348
AN - SCOPUS:85167985127
SN - 2666-6367
VL - 29
SP - 592
EP - 593
JO - Transplantation and Cellular Therapy
JF - Transplantation and Cellular Therapy
IS - 10
ER -